[Effect of quinoline derivatives on pathogenic and apathogenic intestinal microorganisms].
D000421:Alcaligenes / Q000187:drug effects; D001412:Bacillus subtilis / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D001439:Bacteroides / Q000187:drug effects; D002175:Candida / Q000187:drug effects; D003864:Depression, Chemical; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007422:Intestines / Q000382:microbiology*; D007778:Lactobacillus / Q000187:drug effects; D003904:Mitosporic Fungi / Q000187:drug effects*; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011804:Quinolines / Q000008:administration & dosage*; D012486:Salmonella typhimurium / Q000187:drug effects; D012764:Shigella sonnei / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects
D011804:Quinolines
Der Einfluss von Chinolin-Derivaten auf pathogene und apathogene Darmkeime.